Literature DB >> 15592144

The National Alzheimer's Coordinating Center (NACC) Database: an Alzheimer disease database.

Duane L Beekly1, Erin M Ramos, Gerald van Belle, Woodrow Deitrich, Amber D Clark, Mary E Jacka, Walter A Kukull.   

Abstract

The National Alzheimer's Coordinating Center (NACC) is responsible for developing and maintaining a database of patient information collected from the 29 Alzheimer disease centers (ADCs) funded by the National Institute on Aging. Each of the centers collects center-determined data elements on patients enrolled into its center and transmits a minimum dataset to NACC. Data are managed differently at each center depending on that center's research needs. The centers' data systems vary from a single personal computer running spreadsheet software to a network of servers running an advanced data management system such as Oracle. The challenge for NACC is to expand and adjust previously collected data elements into an integrated database that could be used for administrative as well as research purposes. In addition, NACC sought to allow the centers to have the flexibility they needed for data submission. To accomplish this task, NACC designed a database that contained separate specific datasets each with individual data elements. NACC also designed a data management system to easily collect and manage these data. The NACC web site (www.alz.washington.edu) was created to allow access to the data.

Entities:  

Mesh:

Year:  2004        PMID: 15592144

Source DB:  PubMed          Journal:  Alzheimer Dis Assoc Disord        ISSN: 0893-0341            Impact factor:   2.703


  165 in total

Review 1.  Mild cognitive impairment: pathology and mechanisms.

Authors:  Elliott J Mufson; Lester Binder; Scott E Counts; Steven T DeKosky; Leyla de Toledo-Morrell; Stephen D Ginsberg; Milos D Ikonomovic; Sylvia E Perez; Stephen W Scheff
Journal:  Acta Neuropathol       Date:  2011-11-19       Impact factor: 17.088

2.  Psychometric properties of a structured interview guide for the rating for anxiety in dementia.

Authors:  A Lynn Snow; Cashuna Huddleston; Christina Robinson; Mark E Kunik; Amber L Bush; Nancy Wilson; Jessica Calleo; Amber Paukert; Cynthia Kraus-Schuman; Nancy J Petersen; Melinda A Stanley
Journal:  Aging Ment Health       Date:  2012-02-28       Impact factor: 3.658

3.  Neuropsychiatric symptoms in MCI subtypes: the importance of executive dysfunction.

Authors:  Paul B Rosenberg; Michelle M Mielke; Brian Appleby; Esther Oh; Jeannie-Marie Leoutsakos; Constantine G Lyketsos
Journal:  Int J Geriatr Psychiatry       Date:  2010-09-15       Impact factor: 3.485

4.  Auditory confrontation naming in Alzheimer's disease.

Authors:  Jason Brandt; Arnold Bakker; David Aaron Maroof
Journal:  Clin Neuropsychol       Date:  2010-10-27       Impact factor: 3.535

5.  Antipsychotic Use in a Diverse Population With Dementia: A Retrospective Review of the National Alzheimer's Coordinating Center Database.

Authors:  Glen L Xiong; Teresa Filshtein; Laurel A Beckett; Ladson Hinton
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2015       Impact factor: 2.198

6.  DEVELOPMENT OF CLINICAL DEMENTIA RATING SCALE CUTOFF SCORES FOR PATIENTS WITH PARKINSON'S DISEASE.

Authors:  Kathryn A Wyman-Chick; B J Scott
Journal:  Mov Disord Clin Pract       Date:  2015-04-20

7.  Clinicopathological correlates of depression in early Alzheimer's disease in the NACC.

Authors:  Sarah T McCutcheon; Dingfen Han; Juan Troncoso; Vassilis E Koliatsos; Marilyn Albert; Constantine G Lyketsos; Jeannie-Marie S Leoutsakos
Journal:  Int J Geriatr Psychiatry       Date:  2016-02-14       Impact factor: 3.485

8.  Factors associated with resistance to dementia despite high Alzheimer disease pathology.

Authors:  D Erten-Lyons; R L Woltjer; H Dodge; R Nixon; R Vorobik; J F Calvert; M Leahy; T Montine; J Kaye
Journal:  Neurology       Date:  2009-01-27       Impact factor: 9.910

9.  Clinicopathologic differences among patients with behavioral variant frontotemporal dementia.

Authors:  Mario F Mendez; Aditi Joshi; Kanida Tassniyom; Edmond Teng; Jill S Shapira
Journal:  Neurology       Date:  2013-01-16       Impact factor: 9.910

10.  Decreasing hazards of Alzheimer's disease with the use of antidepressants: mitigating the risk of depression and apolipoprotein E.

Authors:  Shanna L Burke; Peter Maramaldi; Tamara Cadet; Walter Kukull
Journal:  Int J Geriatr Psychiatry       Date:  2017-05-31       Impact factor: 3.485

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.